4-Chlorophenyl 4-(6-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)benzoate

Catalog No. :
ACILKI424
CAS No. :
1311279-90-9
Molecular Formula :
C24H21ClF3N3O2
Molecular Weight :
475.90

IUPAC Name:4-chlorophenyl 4-(6-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)benzoate

4-Chlorophenyl 4-(6-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chlorophenyl 4-(6-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)benzoate
IUPAC Name4-chlorophenyl 4-(6-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)benzoate
MDL No.MFCD19981185
Molecular FormulaC24H21ClF3N3O2
Molecular Weight475.90
SMILESO=C(OC1=CC=C(Cl)C=C1)C2=CC=C(C3=CC(C(F)(F)F)=C(N4CCN(C)CC4)N=C3)C=C2
InChI KeyHIWGWTQZKXEWHC-UHFFFAOYSA-N
Synonym4-[6-(4-Methyl-piperazin-1-yl)-5-trifluoromethyl-pyridin-3-yl]-benzoic acid 4-chloro-phenyl es;4-[6-(4-Methyl-piperazin-1-yl)-5-trifluoromethyl-pyridin-3-yl]-benzoic acid 4-chloro-phenyl ester;Benzoic acid, 4-[6-(4-methyl-1-piperazinyl)-5-(trifluoromethyl)-3-pyridinyl]-, 4-chlorophenyl ester
CAS No.1311279-90-9

Synthetic Route by SureRoute

1. ACILKI424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVAGD263 route compound structure diagram
    ACVAGD2631193-00-6 In Stock
  4. Then
  5. ACILKI424 route product structure diagram
    ACILKI4241311279-90-9
Inquiry

2. ACILKI424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVAGD263 route compound structure diagram
    ACVAGD2631193-00-6 In Stock
  4. Then
  5. ACILKI424 route product structure diagram
    ACILKI4241311279-90-9
Inquiry

Comments (0)